MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Revance Therapeutics Company Profile (NASDAQ:RVNC)

Consensus Ratings for Revance Therapeutics (NASDAQ:RVNC) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $46.33 (135.43% upside)

Analysts' Ratings History for Revance Therapeutics (NASDAQ:RVNC)
Show:
DateFirmActionRatingPrice TargetActions
5/24/2016Brean CapitalReiterated RatingBuy$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016GuggenheimReiterated RatingBuy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016SunTrustInitiated CoverageBuy$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015William BlairReiterated RatingBuy$59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2015Piper JaffrayReiterated RatingOverweight$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2015BMO Capital MarketsReiterated RatingOutperform$24.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha